5S rRNA modificator

CAS No. 1415238-77-5

5S rRNA modificator( 5S rRNA modificator )

Catalog No. M17282 CAS No. 1415238-77-5

5S rRNA modificator, used in 5S rRNA RNA modification, is a suitable electrophile for 2’-hydroxyl acylation on structured RNA molecules.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
5MG 42 In Stock
10MG 73 In Stock
25MG 149 In Stock
50MG 249 In Stock
100MG 360 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5S rRNA modificator
  • Note
    Research use only, not for human use.
  • Brief Description
    5S rRNA modificator, used in 5S rRNA RNA modification, is a suitable electrophile for 2’-hydroxyl acylation on structured RNA molecules.
  • Description
    5S rRNA modificator is a rRNA modification agent. 5S rRNA modificator worked as an electrophile for 2’-hydroxyl acylation on structured RNA molecules, yielding accurate structural information comparable to that obtained with existing probes; 5S rRNA RNA modification.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5S rRNA modificator
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    1415238-77-5
  • Formula Weight
    176.17
  • Molecular Formula
    C9H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 52 mg/mL (295.17 mM)
  • SMILES
    Cc1c(cco1)C(=O)n1ccnc1
  • Chemical Name
    Imidazol-1-yl-(2-methylfuran-3-yl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Spitale RC, et al. RNA SHAPE analysis in living cells. Nat Chem Biol. 2013 Jan;9(1):18-20.
molnova catalog
related products
  • BAY 80-6946

    BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Kα/β with IC50 of 0.469 nM/3.72 nM. Phase 2.

  • Umbralisib

    Umbralisib (RP5264,TGR1202, TGR-1202) is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.

  • SRX3207

    SRX3207 is an inhibitor of Syk and PI3K and relieves tumor immunosuppression.